Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4004508 | American Journal of Ophthalmology | 2008 | 6 Pages |
Abstract
The intravitreal injection of 2.5 mg bevacizumab seemed to have no harmful effects on the corneal endothelium.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Chun-Chi Chiang, Wen-Lu Chen, Jane-Ming Lin, Yi-Yu Tsai,